NO994527L - 2,3-dihydrofuro[3,2-b]pyridin, dets fremstilling og anvendelse derav i terapi - Google Patents

2,3-dihydrofuro[3,2-b]pyridin, dets fremstilling og anvendelse derav i terapi

Info

Publication number
NO994527L
NO994527L NO994527A NO994527A NO994527L NO 994527 L NO994527 L NO 994527L NO 994527 A NO994527 A NO 994527A NO 994527 A NO994527 A NO 994527A NO 994527 L NO994527 L NO 994527L
Authority
NO
Norway
Prior art keywords
group
alkyl group
hydrogen atom
compounds
dihydrofuro
Prior art date
Application number
NO994527A
Other languages
English (en)
Norwegian (no)
Other versions
NO994527D0 (no
Inventor
Alistair Lochead
Samir Jegham
Frederic Galli
Thierry Gallet
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO994527D0 publication Critical patent/NO994527D0/no
Publication of NO994527L publication Critical patent/NO994527L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO994527A 1997-03-20 1999-09-17 2,3-dihydrofuro[3,2-b]pyridin, dets fremstilling og anvendelse derav i terapi NO994527L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9703395A FR2761072B1 (fr) 1997-03-20 1997-03-20 Derives de 2,3-dihydrofuro[3,2-b]pyridine, leur preparation et leur application en therapeutique
PCT/FR1998/000531 WO1998042713A1 (fr) 1997-03-20 1998-03-17 DERIVES DE 2,3-DIHYDROFURO[3,2-b]PYRIDINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Publications (2)

Publication Number Publication Date
NO994527D0 NO994527D0 (no) 1999-09-17
NO994527L true NO994527L (no) 1999-11-18

Family

ID=9505006

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994527A NO994527L (no) 1997-03-20 1999-09-17 2,3-dihydrofuro[3,2-b]pyridin, dets fremstilling og anvendelse derav i terapi

Country Status (22)

Country Link
US (1) US6143761A (bg)
EP (1) EP0971929A1 (bg)
JP (1) JP2001518099A (bg)
KR (1) KR20000076282A (bg)
CN (1) CN1251105A (bg)
AR (1) AR012097A1 (bg)
AU (1) AU6924298A (bg)
BG (1) BG103684A (bg)
BR (1) BR9808346A (bg)
CA (1) CA2282320A1 (bg)
CO (1) CO4940417A1 (bg)
EE (1) EE9900414A (bg)
FR (1) FR2761072B1 (bg)
HU (1) HUP0002335A3 (bg)
IL (1) IL131254A0 (bg)
NO (1) NO994527L (bg)
NZ (1) NZ337566A (bg)
PL (1) PL335759A1 (bg)
SK (1) SK127699A3 (bg)
TR (1) TR199902115T2 (bg)
WO (1) WO1998042713A1 (bg)
ZA (1) ZA982365B (bg)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790474B1 (fr) * 1999-03-05 2001-04-06 Synthelabo Derives de pyridopyranoazepines, leur preparation et leur application en therapeutique
SE9902267D0 (sv) * 1999-06-16 1999-06-16 Astra Ab New compounds
JP2005104838A (ja) * 2003-01-09 2005-04-21 Tanabe Seiyaku Co Ltd 縮合フラン化合物
US7780981B2 (en) 2004-09-13 2010-08-24 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
JP2010523587A (ja) 2007-04-02 2010-07-15 パーキンソンズ インスティテュート 治療処置の副作用の低減のための方法および組成物
CA2974324A1 (en) 2015-01-28 2016-08-04 Zita S. Netzel Drug delivery methods and systems
US9585867B2 (en) 2015-08-06 2017-03-07 Charles Everett Ankner Cannabinod formulation for the sedation of a human or animal
CA3049529A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
JP7420797B2 (ja) 2018-05-29 2024-01-23 モーニングサイド ベンチャー インベストメンツ リミテッド 薬剤送達の方法及びシステム

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4176147B2 (ja) * 1995-07-28 2008-11-05 アボツト・ラボラトリーズ 化学的シナプス伝達の制御に有用なフロピリジン、チエノピリジン、ピロロピリジンおよび関連するピリミジン、ピリダジンおよびトリアジン化合物

Also Published As

Publication number Publication date
CO4940417A1 (es) 2000-07-24
ZA982365B (en) 1998-09-23
KR20000076282A (ko) 2000-12-26
BR9808346A (pt) 2000-05-23
US6143761A (en) 2000-11-07
NO994527D0 (no) 1999-09-17
WO1998042713A1 (fr) 1998-10-01
EP0971929A1 (fr) 2000-01-19
SK127699A3 (en) 2000-05-16
EE9900414A (et) 2000-04-17
AU6924298A (en) 1998-10-20
AR012097A1 (es) 2000-09-27
IL131254A0 (en) 2001-01-28
FR2761072B1 (fr) 1999-04-23
FR2761072A1 (fr) 1998-09-25
NZ337566A (en) 2000-09-29
PL335759A1 (en) 2000-05-22
TR199902115T2 (xx) 2000-01-21
CA2282320A1 (en) 1998-10-01
HUP0002335A2 (hu) 2001-05-28
CN1251105A (zh) 2000-04-19
HUP0002335A3 (en) 2002-07-29
JP2001518099A (ja) 2001-10-09
BG103684A (bg) 2000-06-30

Similar Documents

Publication Publication Date Title
GB9921150D0 (en) Therapeutic agents
HUP0301069A2 (hu) Új biaril-karboxamidok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
ES2000299A6 (es) Procedimiento para la preparaciom de nuevos derivados de n-aralquil-piperinmetanol
NO990304L (no) Substituerte triazol-pyridazolderivater som ligander for GABA reseptorer
MA30631B1 (fr) Inhibiteurs de tyrosine kinase
NO20021357L (no) Amino-substituerte pyrazolo[1,5-a]-1,5-pyrimidiner og pyrazolo[1,5-a]-1,3,5-triaziner
BG101806A (bg) Индолови производни като антагонисти на 5-нт рецептори
WO2002076946A3 (en) Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain.
DK1112106T3 (da) Serotonerge 5HT2-agonister til behandling af glaukom
NO20021356L (no) Alkylendiamin-substituerte pyrazolo[1,5,-a]-1,5-pyrimidiner og pyrazolo[1,5-a]-1,3,5-triaziner
NO972910L (no) Tetracykliske spiroforbindelser, fremgangsmåte for fremstilling og anvendelse derav som 5HT1D reseptor-antagonister
EP0445811A3 (en) Nitrogen-containing heterocyclic compounds, their production and use
NO994527L (no) 2,3-dihydrofuro[3,2-b]pyridin, dets fremstilling og anvendelse derav i terapi
NO20010151L (no) N-substituerte naftalenkarboksamider som neurokininreseptorantagonister
DE60108639D1 (de) Aryl- und heteroaryldiazabicycloalkane, deren zubereitung und verwendung
UA66865C2 (uk) Інденопіролокарбазоли, фармацевтична композиція, спосіб інгібування кіназної активності та спосіб лікування (варіанти)
WO2002004455A3 (en) 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof
NO963731L (no) Behandling av obsessive-kompulsive sykdommer med 5HT2-antagonister
NO20000957L (no) Forgrenede alkoksy-substituerte 2-aminopyridiner som NOS inhibitorer
NO20080417L (no) Benzosykloheptapyridiner som inhibitorer av reseptortyrosinkinasen MET
CA2360754A1 (en) Use of pyridazino[4,5-b]indole-1-acetamide derivatives for preparing medicines for treating diseases related to the dysfunction of peripheral benzodiazepin receptors
MX9806171A (es) Derivados 2,3-benzodiazepina y sus usos como inhibidores del receptor-ampa.
DK1194415T3 (da) Nye piperazinylalkylthiopyrimidinderivater, farmaceutiske sammensætninger indeholdende disse samt en fremgangsmåde til deres fremstilling
NZ501417A (en) Crystalline polymorphs of descarbonylethoxyloratadine (8-chloro-6, 11-dihydro-11-(4-piperidylidene)-5H-benzo[5,6] cyclohepta[1,2-b]pyridine) and methods for their use
NO308658B1 (no) Sammenføyde isoquinoliner som dopamin-reseptor-ligander

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application